<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>The EMBO Journal vol.14 23 pp.5939-5946, 1995 <br />  <br />  <br /> REG1 binds protein phosphatase type 1 regulates glucose repression Saccharomyces <br /> cerevisiae <br />  <br />  <br /> Jiangling Tu Marian Carlsonl&quot;2                                cycle progression (Durfee et al., 1993; Dohadwala et al., <br />                                                                   1994). Mitotic defects associated Integrated Program Cellular Biology, Molecular Biology     mutations PP1 genes Schizosaccharomyces pombe <br /> Biophysics Studies, Columbia University, New York, NY 10032   (dis2+1bwsJl sds2J+; Booher Beach, 1989; <br /> lInstitute Cancer Research Departments Genetics     Ohkura et al., 1989; Kinoshita et al., 1990), Aspergillus <br /> Development Microbiology, 701 W 168th Street, <br /> HHSC922 Columbia University, New York, NY 10032, USA              nidulans (bimG+; Doonan Morris, 1989) Droso- <br /> 2Corresponding author                                             phila (PPI 87B; Axton et al., 1990). yeast Saccharo- <br />                                                                   myces cerevisiae, protein phosphatase type 1 encoded <br /> Protein phosphatase type 1 (PP1) encoded GLC7,              GLC7 (DIS2S1), essential gene (Ohkura et al., essential gene Saccharomyces cerevisiae.                1989; Feng et al., 1991). Like mammalian counterparts, <br /> GLC7 phosphatase required glucose repression               GLC7 protein phosphatase participates regulation appears function antagonistically SNF1              diverse processes, including glycogen accumulation <br /> protein kinase. Previously, characterized muta-              sporulation (Feng et al., 1991; Cannon et al., 1994), <br /> tion, gk7-T152K, relieves glucose repression             cell cycle progression (Francisco et al., 1994; Hisamoto <br /> does interfere function GLC7                   et al., 1994; Zhang et al., 1995) protein translation <br /> glycogen metabolism. proposed mutant                  (Wek et al., 1992). Previously, shown GLC7TlS2K phosphatase defective interaction             GLC7 protein phosphatase role regulatory regulatory subunit directs participation           mechanism glucose repression, acting antagonistically <br /> PP1 glucose repression mechanism.                  SNF1 protein kinase (Tu Carlson, 1994).  <br /> present evidence REG1, protein required                explored role. <br /> glucose repression, regulatory subunit.                SNF1 protein kinase required expression REG1 physically associated GLC7.                glucose-repressed genes glucose limiting (Celenza <br /> REG1 interacts GLC7 strongly specifically                Carlson, 1986). SNF1 physically associated hybrid  REG1 GLC7 fusion                large complex proteins, including SNF4 <br /> proteins immunoprecipitate cell extracts.                 activating subunit members family SNF1 -  overexpression REG1 fusion protein                 interacting proteins (SIPI, SIP2, GAL83; Yang et al., <br /> suppresses gk7-T152K mutant defect glucose                  1992). Genetic evidence suggests glucose- <br /> repression. genetic evidence indicate              repressed genes, SNF1 functions relieve transcriptional proteins function regulating             repression mediated MIGI, SSN6 TUPI (Nehlin <br /> glucose repression. results suggest REG1             Ronne, 1990; Keleher et al., 1992; Treitel Carlson, regulatory subunit PP1 targets activity           1995). relationship GLC7 SNF1 protein <br /> proteins glucose repression regulatory pathway.             kinase evident isolated GLC7 gene <br /> Keywords: glucose repression/protein phosphatase 1/regu-           complementation mutation  cidl-226) <br /> latory subunitlSaccharomyces cerevisiae                            partially relieves glucose repression SUC2 <br />                                                                    (invertase) MAL3 (maltase) gene expression (Tu                                                                    Carlson, 1994). showed mutation allele <br />                                                                    GLC7, renamed glc7-T152K. Genetic analysis suggests <br /> Introduction                                                       GLC7 protein phosphatase acts antagonistically reversible phosphorylation proteins major post-        SNF1 protein kinase glucose repression; various <br /> translational regulatory mechanism eukaryotic cells.            different relationships PP1 SNF1 phosphorylation state protein depends            glucose response mechanism possible. <br /> relative activities protein kinases protein phosphat-          interesting aspect genetic analysis ases. kinases phosphatases shown             glc7-T152K allele confers phenotype distinct <br /> play critical roles regulating diverse cellular processes       characterized mutation, glc7-1 <br /> (Hunter, 1987; Cohen, 1989, 1992; Hubbard Cohen,               (Feng et al., 1991; Cannon et al., 1994; Stuart et al., <br /> 1993).                                                              1994). showed glc7-T152K does impair <br />    major protein phosphatases                  glycogen accumulation, glc7-1 abolishes glyco- <br /> eukaryotic cells protein phosphatase type 1 (PP1). PPI          gen accumulation does affect glucose repression highly conserved, &gt;80% identity yeast              (Tu Carlson, 1994). proposed glc7-TJ52K mammals (Ohkura et al., 1989; Feng et al., 1991)               interferes interaction phosphatase participates different cellular regulatory             catalytic subunit regulatory subunit specifically <br /> mechanisms. Mammalian PP1 affects regulation glyco-             directs GLC7 activity target protein(s) involved <br /> gen metabolism, protein synthesis muscle contraction           glucose repression gene expression. <br /> (Cohen, 1989) implicated control cell              mammalian systems, considerable evidence indicates <br />  <br />    Oxford University Press <br />                                                                                                                           5939 <br />  J.Tu M.Carlson <br />  regulatory subunits play major roles controlling       Table  REGI interacts GLC7 hybrid PP1 activity specific substrates (Cohen, 1989; <br /> Hubbard Cohen, 1993). Specific regulatory targeting     DNA-binding           Activation            Colora&apos;     1-Gal activityb <br />  subunits direct PP1 catalytic subunit different        hybrid                hybrid                            Glu       Raf <br />  subcellular locations substrates alter regulatory <br /> properties. example, skeletal muscle, glycogen-     LexA-REG            GAD                   white       &lt;1         binding (G) regulatory subunit targets catalytic subunit   LexA                  GAD-GLC7              white       &lt;1         glycogen particles (Cohen, 1989). regulatory           LexA-REGI             GAD-GLC7              blue        130       24 <br />                                                                LexA-REG            GAD-GLC7TI52K         blue         20       10 <br />  subunits conserved mammals yeast.              LexA-GLC7             GAD-GACI              blue           1      10 <br /> S.cerevisiae, GACI protein sequence homolog        LexA-GLC7TI52K        GAD-GACI              blue          2       20 <br />  mammalian G subunit involved activation          LexA-GLC7             GAD-SNF1              white       &lt;1        &lt;1 <br /> glycogen synthase glycogen accumulation (Fran,ois          LexA-REG            GAD-GACI              white       ND        ND <br />  et al., 1992).  glycogen accumulation defect     aFour transformants patched selective SC-2% glucose plates, <br />  glc7-1 attributed defect interaction   grown 1 day color transformants determined <br />  mutant PP1 catalytic subunit GACI (Stuart et         filter assay. <br /> al., 1994). potential regulators PP1 include GLC8,    bTransformants grown selective SC medium containing  inhibitor-2 homolog (Cannon et al., 1994), SHPI        4% glucose (Glu, repressing condition) 0.05% glucose plus 4% <br />                                                                raffinose (Raf, derepressing condition). ,B-galactosidase activity  (Zhang et al., 1995). S.pombe, sds22 protein           expressed Miller Units. Values averages assays  associates alters substrate specificity PP1   different transformants. Standard errors &lt;10%. <br /> catalytic subunits encoded dis2+ sds2l+ (Stone          ND, determined. <br />  et al., 1993) genetic evidence supports idea  sds22 regulates mitotic function PP1 (Ohkura       Results <br />  Yanagida, 1991). S.cerevisiae homolog EGPI/SDS22 <br />  similar properties (Hisamoto et al., 1995; MacKelvie       REG1 interacts GLC7 hybrid <br /> et al., 1995).                                                     sought identify regulatory subunit       test interaction REG 1 GLC7 controls GLC7 function glucose repression          proteins, used hybrid (Fields regulatory mechanism. protein encoded REG]              Song, 1989). expressed hybrid proteins containing <br />   called HEX2 SRNI) possible candidate.      LexA fused REG1 GAL4 activation domain <br /> REG] identified negative regulator           (GAD) fused GLC7. Interaction fusion <br /> glucose-repressed genes mutation REG] relieves        proteins vivo monitored activation 3- <br /> glucose repression genes (Entian                   galactosidase expression lexAop-GALI-lacZ target <br /> Zimmermann, 1980; Matsumoto et al., 1983; review           gene (Table . Strains expressing LexA-REGI Johnston Carlson, 1992). regi mutation (called       GAD-GLC7 turned blue color assay, control <br /> srnl) identified suppressor mal-],      strains white (Table . additional controls, affects pre-RNA processing transport (Tung et al.,         did detect blue color transformants expressing <br />  1992); RNA1 homologous human Ran GTPase-                LexA-REG 1 combination GAD-GAC 1  activating protein (Bischoff et al., 1995). connection       fusion protein codon 53; Materials methods) GLC7 REG] established             GAD-SIPI (Yang et al., 1992). GAD-REGl fusion <br /> glc7 (called cidl) reg] alleles isolated         constructed expressed did comple- <br /> search mutants defective glucose repression          ment regi mutation interaction LexA- <br /> SUC2 (Neigebom Carlson, 1987; Tu Carlson,              GLC7 detected (data shown). <br />  1994). glc7-T152K regl-69 alleles isolated             Genetic evidence indicates REG1 function search shown functionally similar           required repression gene expression growth snfl epistatic double mutant          glucose. Expression REG] gene regulated <br /> combination showed synergy relieving repression          glucose availability (Niederacher Entian, 1991). SUC2. genetic analysis suggests genes       test interaction REGI GLC7 function glucose repression SUC2.         modulated glucose availability, quantitatively  considered REG1 candidate             assayed ,B-galactosidase activity resulting inter- <br /> GLC7 regulatory subunit. REG1 113 kDa protein             action LexA-REG 1 GAD-GLC7 hybrid <br /> containing putative nuclear localization signals               glucose-repressing -derepressing <br /> (Niederacher Entian, 1991; Tung et al., 1992).             conditions (Table . proteins expressed     tested model REG1 protein        strong ADHI promoter. glucose-grown cells, 3- associated GLC7 protein phosphatase.      galactosidase expression stimulated &gt;100-fold <br /> used hybrid REGI               (130 U) relative controls. raffinose-grown cells, <br /> GLC7 interact strongly specifically. present         3-galactosidase activity substantial (24 U), <br /> biochemical evidence REG1 GLC7 proteins           5-fold lower glucose-repressing condi- <br /> interact physically. Finally, genetic evidence lends   tions. contrast, cells expressing LexA-GLC7 (Tu <br /> support idea proteins function    Carlson, 1994) GAD-GAC 1, 3-galactosidase regulating glucose repression. data suggest      activity 10-fold higher derepressing conditions. <br /> REGI potential regulatory subunit PPI             results indicate GLC7 phosphatase interacts <br /> targets activity proteins glucose repression     strongly REG 1 glucose-repressing regulatory pathway.                                            derepressing conditions. addition, possible 5940 <br />                                                                                       Yeast protein phosphatase 1 regulatory subunit <br />  <br />  <br /> Table II. Overexpression LexA-REG 1 restores glucose repression      fold decreased hybrid interaction detected SUC2 expression glc7-T152K mutant                               derepressed cells. <br /> Relevant genotype    Expressed protein     Invertase activity           g/c7-T152K mutation decreases interaction <br />                                            Repressed      Derepressed   GLC7 REG1 <br />                                                                         proposed glucose repression defect glc7-T152K           LexA                   26            250           glc7-TJ52K mutant results defect interaction <br />                      LexA-GLC7               2            220           GLC7Tl12K mutant protein regulatory <br />                      LexA-GLC7TI52K         21            230 <br />                      LexA-REG 1              2            140           subunit (Tu Carlson, 1994). test defect                                                                         interaction REG1, used hybrid reglA::URA3          LexA                  240            230           compare interaction wild-type mutant GLC7 <br />                      LexA-REGI               4             74 <br />                      LexA-GLC7             220            260           proteins LexA-REG1. expressed derivative <br />                                                                         GAD-GLC7 carrying glc7-TJ52K mutation, called <br /> Invertase activity expressed gmol glucose releasedJmin/100 mg     GAD-GLC7Tls2K. reagents cells (dry weight). Cultures grown selective SC-2% glucose      detect GAD-GLC7 fusion proteins, evidence <br /> (repressed) shifted SC-0.05% glucose medium 3 h              indicates T152K alteration does affect stability <br /> (derepressed). Values averages transformants MCY2616 (glc7-T152K) MCY3278 (reglA::URA3). LexA                protein: LexA fusions mutant wild-type <br /> expressed pLexA(l-202)+PL (Ruden et al., 1991). Standard           GLC7 present level   wild- <br /> errors &lt;20%.                                                       type mutant GLC7-lacZ fusions (Tu Carlson, <br />                                                                         1994) produced P-galactosidase activity (unpub- fold regulatory effect detected reflects                 lished data). <br /> physiologically significant regulation interaction                  glucose-grown strains, LexA-REGI combination native proteins.  deter-                mutant GAD-GLC7Tl52K fusion protein produced <br /> mined protein levels affected glucose                    6-fold 0-galactosidase activity LexA-REGI induction ADHI promoter.                                         combination wild-type GAD-GLC7 (Table .                                                                         findings suggest GLC7Tl52K mutant protein REG1 GLC7 fusion proteins                                        partially defective interaction REG1 vivo. <br /> immunoprecipitate                                                        defect interaction native proteins provide biochemical evidence REG1 GLC7                      expressed chromosomal loci probably protein phosphatase interact, carried immuno-                 severe indicated 6-fold decrease detected <br /> precipitation experiments. Extracts prepared                  overexpression fusion proteins <br /> glucose-grown cells expressing LexA-REG 1                      compensates mutant defect  . <br /> HA-GLC7 (Sutton et al., 1991), carries hema-                       similar experiment, mutant GLC7Tl52K fusion <br /> glutinin (HA) epitope tag. LexA-REG1 complements                      protein showed defect interaction GAC1, regi mutation (Table II) HA-GLC7 provides GLC7                      glycogen regulatory subunit PP1 (Table . function (Stuart et al., 1994). HA-GLC7 protein                 consistent previous evidence glc7-TJ52K mutant <br /> immunoprecipitated monoclonal HA antibody                      cells accumulate nearly normal levels glycogen. precipitate analyzed Western blotting                contrast, GACI shows defect interaction presence LexA-REGI using LexA antibody (Figure                       product glc7-1 allele, reduces glycogen <br /> IA). addition, LexA-REGI immunoprecipitated                      accumulation (Stuart et al., 1994).  specificity LexA antibody precipitates similarly                  interaction defect correlates phenotype. <br /> analyzed presence HA-GLC7 using HA antibody <br /> (Figure 1 B). case, REG 1 GLC7 fusion                   Overexpression LexA-REGI suppresses proteins immunoprecipitated. Control experiments                glc7-T152K mutant defect glucose repression <br /> LexA-SIPI (Yang et al., 1992) HA-SIP4 fusions                       glucose repression defect glc7-TJ52K mutant <br /> ruled artifactual interactions involving LexA                partial defect interaction PP1 REGI, <br /> HA moieties. addition, detected protein phosphatase               reasoned increased levels REGI expression <br /> activity  Figure 3) coprecipitating LexA-REGI                  partially compensate defect LexA-SIP1 (data shown).                        suppress glc7-T152K phenotype. test possibility <br /> glucose-repressed cells GLC7 protein phosphatase                 introduced pLexA-REG1, expresses fusion <br /> physically associated REGI.                                        protein strong ADHI promoter, glc7- <br />    extracts prepared derepressed cultures,               T152K mutant assayed invertase activity. Glucose able detect immunoprecipitation                    repression SUC2 expression restored; fact, LexA-REGI HA-GLC7 amounts LexA-                          defect suppressed effectively LexA-REGI REGI protein greatly decreased (&gt;20-fold) relative                 LexA-GLC7 (Table II). contrast, overexpression levels glucose-repressed extracts (data             LexA-GLC7 did suppress reglA defect glucose <br /> shown).  detected similar amounts LexA-                   repression. data consistent hybrid <br /> REGI repressed derepressed cultures cells                   evidence glc7-TJ52K mutation reduces interaction boiled directly gel loading buffer.                   GLC7 REG 1, suppression LexA- <br /> results, positive hybrid results               REGI overexpression accounted derepressed cells, suggest LexA-REG1 simply                 mechanisms.  findings provide additional <br /> stable derepressed extracts. know              genetic evidence GLC7 REGI function apparent instability related mechanistic level             glucose repression. <br />  <br />                                                                                                                                5941 <br />  J.Tu M.Carlson <br />  <br />                                        LexA-REG1                           B                       HA-GLC7 <br />                                   HA-GLC7 +    -                                  LexA-REGI           + <br />                                   HA-SIP4 -    +                                  LexA-SIP1           -       + <br />                          IP:     X-HA                           220        IP: cif-LexA        &gt; <br />                          Blot:      uf-LexA                                  Blot:  HA <br />                                                                                                                    ~~29 <br />                                                                   97 <br />  <br />                          Input <br />                           1t                                  ~~~~22020      Input               &gt;M4         s- <br />  <br />                          Blot: (-f-LexA                                      Blot:    (iX-HA                        29 <br />                                                                   -97 <br />  <br />                                                                   97 <br />                          IP:  (-/-HA                                         IP: c-y-LexA <br />                          Blot: ( HA <br />                                                               -   66 <br />                                                                              Blot: ct-LexA <br />                                                               -   46 <br />  <br />  <br />  <br /> Fig. 1. immunoprecipitation LexA-REGI HA-GLC7. Protein extracts (250 gg) prepared glucose-grown wild-type strain <br /> MCY3237 expressing indicated proteins. HA-tagged proteins   LexA fusions (B) immunoprecipitated (IP) anti -HA anti - <br /> LexA antibodies, respectively. Precipitated proteins separated SDS-PAGE immunoblotted HA LexA, indicated panel. Upper panels immunoprecipitation LexA-REGI   HA-GLC7 (B). Lower panels immunoblot reprobed primary antibody confirm precipitation HA-tagged protein   LexA fusion (B). Middle panels immunoblots input proteins (25 ,ug). smaller LexA-REGI species presumably degradation products. HA-SIP4 (98 kDa; gift P.Lesage) LexA-SIPI (130 kDa; Yang et al., 1992) negative controls. Size standards indicated kDa. Positions LexA-REGl (closed arrows) HA-GLC7 (open arrows) marked. <br />  <br />   assayed invertase expression strains                     Table III. glc7-T152K reglA::URA3 relieve glucose repression derepressing conditions (Table II). Overexpression LexA-REGI significantly reduced derepression                          Relevant genotype                       Invertase activity <br /> SUC2 expression, suggesting REGI function                                                               Repressed        Derepressed negative regulator gene expression glucose- <br /> repressed -derepressed cells.                                           Wild-type                                 2              390 <br />                                                                             reglA::URA3                             320              410 <br /> Genetic analysis regi gkc7-T152K                                     glc7-TJ52K                               53              360 <br />                                                                             glc7-T152K regJA::URA3                  280              370 compare phenotypic effects glc7-TJ52K regi null allele, constructed set strains               Invertase activity expressed Table II. Strains grown genetic background. introduced reglA::URA3,                      mid-log phase YEP-2% glucose (repressed) shifted YEP- <br /> deletion codons 52-480 (Tung et al., 1992),                       0.05% glucose (derepressed) 2.5 h. Values averages assays <br /> wild-type diploid  Materials methods). Southern                     different segregants. Standard errors &lt;21%. <br /> blot analysis confirmed disruption. Tetrad analysis diploids heterozygous regi disruption showed                        supports view glc7-T152K reglA relieve <br /> 2+:2- segregations growth YEP-2% sucrose                         glucose repression pathway. <br /> taining glucose analog 2-DG, indicating                           reglA glc7-TJ52K cause distinct <br /> disruptants resistant glucose repression SUC2.                    phenotypes respect various processes disrupted REG] locus heterozygous                          glucose repression.  course tetrad <br /> +/glc7-T152K diploid recovered single mutant                       analysis, noted difference regi glc7- glc7-T152K reglA:: URA3 double mutant segregants.                       T152K growth phenotypes. dissection, glc7- <br />    Mutant segregants assayed invertase activity                    TJ52K spore clones grew normally regi spores <br /> (Table III). reglA mutation completely relieved                         slow form visible spore clones sub- <br /> glucose repression SUC2, indicating REG]                         sequently showed normal growth. <br /> absolutely required glucose repression regulatory                      Second, assayed mutant strains glycogen <br /> mechanism. contrast, glc7-TJ52K caused partial                    accumulation using iodine staining method (Figure <br /> release, consistent model glc7-TJ52K reduces                  2). glc7-TJ52K mutant cells accumulated glycogen <br /> interaction GLC7 REG1, partially                        wild-type, consistent quantitative <br /> impairing repression. double mutant segregants                          assays (Tu Carlson, 1994) glc7-1 cells showed quantitatively similar defects glucose repression                 completely deficient (Fran,ois et al., 1992; Cannon et al., SUC2 expression reglA single mutants; additive                     1994). reglA mutant cells deficient, sug- <br /> effect synergy observed (Table III). similarity                  gesting reglA does cause general defect single double mutant phenotypes                     PP1 activity. Surprisingly,  accumulated <br />  <br /> 5942 <br />                                                                                              Yeast protein phosphatase 1 regulatory subunit <br />  <br />  <br />  <br />                    S                      ~~~~glc7-1                       - <br />  <br />  <br />  <br />  <br />                                              WT                             <br />  <br />                                                                            E <br />                                              reg 1A::URA3 <br />                                                                              <br />                                              gic7-T1 52K <br />                                                                                         1       2    3     4               1       2    3     4 <br /> Fig. 2. Glycoeen acCL umuLlmation mutltants wild-type. Yeast <br /> Colonics wcrc patched onito YEP-2&quot; g(ILIucOSC plates. incubated 30W-C                    GLC7     GLC7Tl52K                 GLC7     GLC7T152K <br /> f 24 h stalined iodinc vapor. Strains JC782.24D                            LexA Fusion Protein                LexA Fusion Protein <br /> (Oc7-/). 1FY2(5 (wild-type. W&apos;T). MICY3278 (rcoJ1A..:lR.43)                                                                            Fig. 3. Protein phosphatase activity immunoprecipitated wxild-type <br />                                                                            mutanit GLC7 fusion protein. Protein extracts (&gt;0 pgT)                                                                            prepared f&apos;rom glucose-grown transformiiants wIldts p .str FY250) <br />                                                                            expressing LexA-GLC7 LexA-GLC7T] -K, indicated. <br />  clvcoen somewhat higher levels wild-type.                     Transformants carried pRS424 sector (bairs 3) basis enhanced accumulation clear                      pRJ85 (REGI pRS424) (bars 2 4). LexA fusions Discussioni).                                                              imminuLinoprecipitated anti-LexA antibod.   Phosphatase assays <br />    Finally. diploids homozygous reugIA sporulated                      immiiiiunoprecipitate beads performiied using - <br />                                                                            phosphorylase a1s substrate. (B) Immunoprecipitates efficientlN, diploids homozygous gic7-T152K                      treated <span id='am-7' about='obo:IMR_0200324' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-8' property="rdfs:label" content="CO2" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:id" content="IMR:0200324" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:hasDbXref" content="KEGG:C00011" datatype="xsd:string"></span>Co2</span>-/trypsin stimulate phosphatasesactitittv  defective, previously shown (Neigebom                          Materials methods) assaved. transformanllts ot&apos; Carl-son. 1 987). dramatic phenotypic difference sug-                 type assayed. mmunoblot analvsis saiamples used gests possibility gic7-T152K affects                    bars aind 3 showed wild-type mutant fusions expressed <br /> aspect ot GLC7 function independent REGI.                       levels. addition. transformants expressing LexA-GLC7 <br />                                                                            GAD-GACI assayed values simillar examiiple, interaction regulatory protein             transformants carrvitg multicopy REG plasmid. Bars represent intrinsic   enzymatic actiNlity.                                    phosphataise activity -&apos;P c.p.m. released assay. Standaird <br />                                                                            deviations indicated. <br /> LexA-GLC7Tl52K partially defective phosphatase activity vitro                                              hybrid \x e showed LexA-REG GAD- <br /> Genetic e-vidence argues drastic overall reduction               GLC7 interact n tito. demonstrated LexA- activity otf mutant GLC7Tl&apos;-K phosphatase: gl(7-                    REGI HA-GLC7 fusion proteins immunoprecipi- <br /> T152K mutants normal growth glycogen                              tate cell extracts. Finally, genetic analysis indicates <br /> accun]ulation. null mutants inviable gic 7-1               REGI GLC7 function affect glucose <br /> mutants fail accumulate glycogen.  different                    repression. Mutations genes relieve glucose repres- <br /> cellular   processes  different thresholds sensi-              sion double mutant combination causes synergy <br /> tivity&apos; PPI activitv sporulation particularly              additive effect. Morev,er, overexpression REGI <br /> sensitive impairment     PPI activity.                  fusion protein effectiv ely suppresses glucose repression <br /> assayed protein phosphatase activity mutant                     defect caused glc7-T152K. findings support  wYild-type LexA fusion proteins. Immunoblot analysis                      model REG regulatory subunit GLC7 showved fusions expressed                       directs PPI activity targets glucose repression <br /> levels (data shown) displayed expected                    pathway. <br /> functional behaviors vi1&apos;0 (Table II). Proteins                       Mutation REGI relieves glucose repression immllunoprecipitated w,ith LexA antibody pre-                      genes tested, including SUC2, MAL3. <br /> cipitates assayed protein phosphatase activity                    GAL], ADH2, HXT2, HXT4 mitochondrial genes <br /> using 32P-labeled phosphorylase substrate (Figure 3A).                  (Entian Zimmermann, 1980; Matsumato et al., 1983; <br /> Precipitates assayed treatment cobalt                 Neigebom Carlson, 1987; Dombek et ail., 1993; Ulery <br /> chloride plus trypsin. followed addition trypsin                     et Cal., 1994: Ozcan Johnston. 1995): genes encoding <br /> inhibitor stimulates protein phosphatase activity                    gluconeogenic enzymes exceptions (Entian (Feng et cil., 1991) (Figure 3B). Activity mutant                   Zimmermann, 1980). major loss glucose repression <br /> LexA-GLC7TI52K w lower LexA-GLC7                        explained absence regulatory subunit titro assays. sueaestina unfused                         mediates effects GLC7 phosphatase GLC7TI&apos; K protein probably reduced phosphatase                         glucose repression. glcZ7-T152K mutation causes activity relative wild-type protein ini vitO.                       limited defects; example. glc 7-T152K does relieve <br />                                                                            glucose repression GAL] promoter (Neigebom Discussion                                                                 Carlson, 1987) ADH2 (Dombek et Cal., 1993)                                                                            partially relieves repression SUC2. suggest present genetic biochemical evidence                      gl(7-T152K causes partial functional defect REG protein physically functionally associated                requirement GLC7-REG 1 function glucose GLC7 type protein phosphatase. Usine                    repression stringent genes  <br />                                                                                                                                             5943 <br />  J.Tu M.Carlson <br />  <br />    glc7-T152K causes phenotypic effect       Table IV. List Saccharomyces cerevisiae strains <br />  subset genes repression sensitive <br />  GLC7-REG1 function.                                         Straina        Genotype <br />      Genetic evidence, hybrid  overexpression studies, consistent idea   MCY835     MATa glc7-T152K lys2-801 ura3-52 <br />                                                                 MCY1093    MATa his4-539 lys2-801 ura3-52 <br />  partial glucose repression defect glc7-TJ52K mutant       MCY2616    MATa glc7-T152K his3A200 lys2-801 trplAl ura3-52 <br />  results decreased interaction REGI            MCY2649    MATa his3A200 leu2-3,112 trplAJ ura3-52 <br />  GLC7Tl52K. possible Thrl52 participates          MCY2921    MATa ade2-101 his3A200 trpJAl ura3-52 <br />  specific protein-protein contact REGI            MCY3263    MATa glc7-T152K reglA::URA3 ade2-101 trpJAl <br />  disrupted mutation Lys.  mutation                 ura3-52 <br />                                                                 MCY3268 MATa reglA::URA3 ade2-101 lys2-801 trpJAl ura3-52 <br />  effects GLC7 function, judged           MCY3278 MATa reglA::URA3 his3A200 leu2AJ trpJA63 ura3-52 <br />  sporulation defect glc7-T152K mutants,         JC782.24Db MATa glc7-1 lys2 leu2 met4 ura3 <br />  shared regi mutants, decreased phosphatase       FY250C     MATa reglA::URA3 his3A200 leu2AJ trpJA63 ura3-52 <br />  activity LexA-GLC7Tl52K protein vitro.          CTY10-5dd MATa gal4 gal80 URA3::1exAop-lacZ ade2-101 <br />  exclude possibility presence Lys                    his3A200 leu2AJ trpIA901 <br />  position 152 alters conformation GLC7            aMCy strains S288C background carry SUC2. <br />  indirectly impairs interaction REG1.     bObtained J.Cannon. <br />  ingly, glc7-1 mutation analogous properties    cObtained F.Winston; S288C genetic background. <br />  impairs interaction GACI regulatory subunit        dConstructed R.Sternglanz (SUNY, Stony Brook). <br />  causes major defect glycogen metabolism  associated pleiotropic phenotypes (Feng et al.,       regulatory subunits  1991; Wek et al., 1992; Cannon et al., 1994; Francisco         association GLC7; REGI absent, greater <br />  et al., 1994).                                                 proportion cellular pool PPl associated <br />     key questions remain open regarding role         GAC 1. second possibility mutation REG] <br />  GLC7-REG1 glucose repression.            causes various physiological changes indirectly result <br />  targets phosphatase activity glucose repression      enhanced glycogen accumulation. example,  mechanism? Previous genetic evidence suggests             glucose repression defect regl mutants cause <br />  GLC7 functions antagonistically SNF1 protein            glycogen accumulation commence earlier stage <br />  kinase phosphorylation SIPI altered immune       growth curve, seen glc7-TJ52K mutant <br />  complex assays SNF1 kinase activity glc7-TJ52K         cultures (Tu Carlson, 1994). Finally, enhanced <br />  mutants (Tu Carlson, 1994). addition, genetic           accumulation reflect effects regi GACI <br />  evidence (Erickson Johnston, 1993) suggested inter-        expression. <br />  action REGI GAL83, protein associa-           REG] shown affect processes ted SNF1 kinase complexes (Yang et al., 1994).             examined glc7-T152K mutants.  regulators SNF1, substrates SNF1 SNF1        example, regi impairs glucose induction HXTJ (glucose <br /> kinase itself potential candidates targets GLC7-     transporter) gene expression (Ozcan Johnston, 1995). <br /> REGI activity.                                                  addition, reglA suppresses mutations affect pre- <br />     second question function REG1         RNA processing transport (Tung et al., 1992); GLC7-REG1 complex, regulated response           case, likely GLC7 involved glucose availability. shown expression      mammalian PP1 implicated mRNA processing REG] gene glucose-regulated (Niederacher         (Mermoud et al., 1994). Tung et al. (1992) suggested <br /> Entian, 1991). Interaction REGI PPI fusion          REGI serve connect RNA processing proteins hybrid appeared regulated      transport carbon source regulation. Alternatively, REGI fold dramatically;  fusion          target PP1 activity substrates involved processes <br /> proteins overexpressed remains possible         glucose repression. interaction native proteins regulated significant extent. possible mechanisms include: <br /> regulation ability REGI recognize substrates,      Materials methods <br /> differential localization REGI GLC7-REG1           Strains genetic methods cell control phosphatase activity inhibitory    Saccharomyces cerevisiae strains listed Table IV. Standard methods <br /> subunit. Finally, conceivable GLC7-REG1              yeast genetic analysis (Rose et al., 1990) transformation (Ito <br /> activity regulated response glucose availability   et al., 1983) followed. 2-Deoxyglucose (2-DG) resistance                                                                 tested YEP (1% yeast extract, 2% bacto-peptone) containing 2% function regulated differential availability   sucrose 200 gg/mI 2-DG (Sigma) anaerobic conditions phosphorylated substrate proteins.                              <span id='am-1' about='obo:IMR_0001720' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-2' property="oboInOwl:hasDbXref" content="MeSH:D005740" datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="gas" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:id" content="IMR:0001720" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-6' property="obo:IAO_0000115" content="The vapor state of matter; nonelastic fluids in which the molecules are in free movement and their mean positions far apart. Gases tend to expand indefinitely, to diffuse and mix readily with other gases, to have definite relations of volume, temperature, and pressure, and to condense or liquefy at low temperatures or under sufficient pressure." datatype="xsd:string"></span>Gas</span> Paks (BBL). Control plates lacked 2-DG. Scoring performed <br />     addition common effects glucose repres-      spotting cell suspensions solid medium. Selective synthetic <br /> sion, glc7-TJ52K reglA mutations cause distinct         complete medium (SC) used grow strains carrying plasmids. phenotypes. sporulation defect glc7-T152K mutants        assess sporulation proficiency, diploid cells grown YEP-2% <br />                                                                 glucose plates overnight, patched sporulation medium (Rose et al., result decreased enzymatic activity                 1990), incubated room temperature 8 days examined <br /> GLC7T152K loss interaction regu-        microscopically presence asci. Escherichia coli strain XLl- <br /> latory subunit directs PP1 function sporulation.        Blue used host plasmids. enhanced glycogen accumulation observed regi <br /> mutants accounted possible       Construction plasmids <br />                                                                 construct GLC7 fusions, designed primers amplify mechanisms.  REGI GAC1 compete               entire GLC7 coding region (codons 1-312) introduce BamHI <br />  <br /> 5944 <br />                                                                                               Yeast protein phosphatase 1 regulatory subunit <br />  <br /> sites 5&apos; 3&apos; gene. 5&apos; primer 5&apos;-CGGGATCCAA-                Glycogen assay <br /> GAAATGGACTCA-3&apos; 3&apos; primer 5&apos;-CGGGATCCTTFTTTT-                    Yeast colonies patched YEP-2% glucose plates, incubated CTTTCTACCCCC-3&apos;. Using PCR, amplified GLC7 sequence               30&#194;&#176;C overnight stained iodine vapor (Chester, 1968). pJT18 (Tu Carlson, 1994). BamHI fragment amplified DNA subcloned BamHI site pGADNOT <br /> (Luban et al., 1993) yield pGAD-GLC7. pGAD-GLC7TI52K                  Acknowledgements <br /> constructed replacing Sail  polylinker site) fragment pGAD-GLC7 SalI-XhoI fragment pJTL18TI52K (Tu               thank R.Jiang, K.T.Arndt, P.Lesage, K.Hopper, J.Cannon Carlson, 1994).                                                              F.Winston plasmids strains E.M.Reimann providing    pRJ85, containing REGI gene pRS424 (Sikorski Hieter,           phosphatase assay protocol. work supported NIH grant <br /> 1989), pLexA-REGl (pRJ65), containing entire REGI coding             GM34095 M.C. <br /> region fused LexA, gifts R.Jiang  laboratory). construct pLexA-REG 1, sequence extending codon 1 REGI          References vector sequence 3&apos; cloned gene amplified PCR pUCSRNI (Tung et al., 1992). EcoRI site introduced 5&apos;          Axton,J.M., Dombradi,V., Cohen,P.T.W. Glover,D.M. (1990) coding sequence reaction. EcoRI-SalI (pUC vector site)              protein phosphatase 1 isoenzymes Drosophila essential fragment amplified DNA cloned cognate sites            mitosis. Cell, 63, 33-46. <br /> pLexA(1-202)+PL (Ruden et al., 1991).  ClaI-SalI fragment           Bischoff,F.R., Krebber,H., Kempf,T., Hermes  Ponstingl,H. (1995) <br /> (ClaI site codon 52) replaced corresponding fragment            Human RanGTPase-activating protein RanGAPl homologue pUCSRN 1, yielding pLexA-REG 1. pHA-GLC7 (CB597), YCpSO                 yeast Rnalp involved mRNA processing transport. Proc. Natl <br /> derivative expressing HA-tagged GLC7, gift K.T.Arndt (Sutton          Acad. Sci. USA, 92, 1749-1753. <br /> et al., 1991). pHA-SIP4 gift P.Lesage  laboratory).          Booher,R. Beach,D. (1989) Involvement type 1 protein disrupt REGI gene, EcoRI-XbaI fragment purified                phosphatase encoded bwsl + fission yeast mitotic control. Cell, <br /> pUCsrnl::URA3 (Tung et al., 1992) used transform (Rothstein,             57, 1009-1016. <br /> 1983) wild-type haploid strain FY250, wild-type diploid strain           Breeden,J. Nasmyth,K. (1985) Regulation HO gene. Cold <br /> MCY1093 X MCY2649 +/glc7-T152K heterozygous diploid strain                  Spring Harbor Symp. Quant. Biol., 50, 643-650. <br /> MCY835 x MCY2921. resulting allele designated                        Cannon,J.,     Pringle,J.R., Fiechter  Khalil,M. (1994) <br /> reglA::URA3.                                                                   Characterization glycogen-deficient glc mutants Saccharomyces <br />     pGAD-GAC isolated plasmid library fusions           cerevisiae. Genetics, 136, 485-503. GAL4 activation domain (GAD) yeast genomic DNA fragments             Celenza,J.L. Carlson,M. (1986) yeast gene essential (Chien et al., 1991 ) hybrid screen GLC7-interacting proteins     release glucose repression encodes protein kinase. Science, <br /> (unpublished data). Sequence analysis indicated GAC 1 fused       233, 1175-1180. <br /> GAD residue 53.                                                           Chester,V.E. (1968) Heritable glycogen-storage deficiency yeast                                                                                 induction ultra-violet light. J. Gen. Microbiol., 51, 49-56. <br /> fi-Galactosidase invertase assays                                        Chien,C.-T., Bartel,P.L., Sternglanz,R. Fields,S. (1991)  test f-galactosidase expression, transformants patched          hybrid  method identify clone genes proteins selective SC-2% glucose, grown day, replicated nitrocellulose        interact protein  Proc. Natl Acad. Sci. USA, 88, <br /> filters, permeabilized (-70&#194;&#176;C 10 min) incubated X-Gal              9578-9582. <br /> overnight (Breeden Nasmyth, 1985). quantitative assays, glucose-     Cohen,P. (1989) structure regulation protein phosphatases. <br /> repressed cultures grown mid-log phase YEP selective SC          Annu. Rev. Biochem., 58, 453-508. <br /> medium containing 2% 4% glucose; derepressed cultures         Cohen,P. (1992) Signal integration level protein kinases, protein <br /> grown 4% raffinose plus 0.05% glucose prepared shifting             phosphatases substrates. Trends Biochem. Sci., 17, 408-413. <br /> YEP SC containing 0.05% glucose 2.5 3 h, respectively. P-          Dohadwala,M., da Cruze e Silva,E.F., Hall,F.L., Williams,R.T., <br /> Galactosidase activity assayed permeabilized cells expressed         Carbonaro-Hall,D , Nairn C., Greengard,P. Berndt,N. (1994) Miller units (Miller, 1972). Invertase activity assayed         Phosphorylation inactivation protein phosphatase cyclin- <br /> cells (Tu et al., 1993).                                                        dependent kinases. Proc. Natl Acad. Sci. USA, 91, 6408-6412. <br />                                                                              Dombek,K.M., Camier,S. Young,E. (1993) ADH2 expression Immunoprecipitation assays                                                      repressed REG 1 independently mutations alter Protein extract immunoprecipitation procedures described            phosphorylation yeast transcription factor ADRI. Mol. Cell. <br /> previously (Yang et al., 1992), extraction buffer 50 mM          Biol., 13, 4391-4399. <br /> HEPES [4-(2-Hydroxyethyl)-l-piperazine-ethanesulfonic acid] pH 7.5,          Doonan,J.H. Morris,N.R. (1989) bimG gene Aspergillus <br /> 100 mM NaCl, 1% Triton X- 100, containing 2 mM phenylmethylsulfonyl             nidulans, required completion anaphase, encodes fluoride mg/ml pepstatin, leupeptin aprotinin             homolog mammalian phosphoprotein phosphatase 1. Cell, 57, <br /> immobilized rProtein (RepliGen) used. Proteins separated             987-996. SDS-PAGE immunoblotted. Primary antibodies anti-LexA             Durfee,T., Becherer,K., Chen,P., Yeh,S., Yang,Y., Kilburn E., Lee,W. <br /> (gift C.Denis) monoclonal HA antibody (12CA5, BabCo).                    Elledge,S.J. (1993) retinoblastoma protein associates Antibodies detected enhanced chemiluminescence ECL                protein phophatase type catalytic subunit. Genes Dev., 7, 555-569. <br /> reagents (Amersham International).                                           Entian,K.-D. Zimmermann,F.K. (1980) Glycolytic enzymes                                                                                intermediates      carbon     catabolite   repression   mutants     Protein phosphatase assay                                                      Saccharomyces cerevisiae. Mol. Gen. Genet., 177, 345-350. <br /> Phosphatase activity immunoprecipitation assayed measur-       Erickson,J.R. Johnston,M. (1993) Genetic molecular <br /> ing release 32p labeled phosphorylase described            characterization GAL83: interaction similarities Feng et al. (1991) following modifications. immuno-               genes involved glucose repression Saccharomyces cerevisiae. <br /> precipitates 250 .g protein extract washed resuspended         Genetics, 135, 655-664. buffer (50 mM imidazole-HCI, pH 7.4, 5 mM EGTA, 2 mM                    Feng , Wilson,S.E., Peng Y., Schlender,K.K., Reiman,E.M. dithiothreitol 0.2 mg/ml BSA). measure Co2+/trypsin-stimulated          Trumbly,R.J. (1991) yeast GLC7 gene required glycogen <br /> phosphatase activity, immunoprecipitates pre-incubated                accumulation encodes type protein phosphatase. J. Biol. Chem., <br /> 0.2 mM CoC12 5 min 30&#194;&#176;C incubated trypsin                       266, 23796-23801. <br /> (0.02 mg/ml) 10 min; soybean trypsin inhibitor added         Fields,S. Song,O. (1989) novel genetic detect protein- <br /> 0.08 mg/ml (Feng et al., 1991). Phosphatase reactions (25 ,ul) contained        protein interactions. Nature, 340, 245-246. <br /> immunoprecipitate beads 60 ,ug protein extract       Francisco,L., Wang,W. Chan,C.S.M. (1994) Type 1 protein <br /> Co2+/trypsin treatment) 40 mM imidazole-HCI, pH 7.4, 4 mM                    phosphatase acts opposition Ipll protein kinase regulating <br /> theophylline, 1.6 mM dithiothreitol, 2 mM EGTA, 0.08 mg/ml BSA.                 yeast chromosome segregation. Mol. Cell. Biol., 14, 4731-4740. <br /> Phosphatase reactions initiated adding [32p] phosphorylase           Francois,J., Thompson-Jaeger,S., Skroch,J., Zellenka,U., Spevak,W. (-5 lg, 50 000 c.p.m.). incubation 30&#194;&#176;C 10 min, reaction      Tatchell,K. (1992) GACI encode regulatory subunit protein terminated addition 35 jt 20% trichloroacetic acid         phosphatase type Saccharomyces cerevisiae. EMBO J., 11, 87-96. <br /> 32P released supernatant measured.                              Hisamoto,N., Frederick,D.L., Sugimoto,K., Tatchell,K.  <br />                                                                                                                                                  5945 <br />   J.Tu M.Carlson <br />  <br />    Matsumoto,K. (1995) EGPl gene positive regulator                  phosphatase required late G progression S phase. Cold <br />    protein phosphatase type 1 growth control Saccharomyces                  Spring Harbor Symp. Quant. Biol., 56, 75-81. <br />    cerevisiae. Mol. Cell. Biol., 15, 3767-3776.                                    Treitel,M  Carlson,M. (1995) Repression SSN6-TUPI  Hisamoto,N., Sugimoto,K. Matsumoto,K. (1994) Glc7 type                     directed MIG  repressor/activator protein. Proc. Natl Acad. Sci. <br />    protein phosphatase Saccharomyces cerevisiae required cell               USA, 92, 3132-3136. <br />    cycle progression G2/M. Mol. Cell. Biol., 14, 3158-3165.                     TuO. Carlson,M. (1994) GLC7 type 1 protein phosphatase  Hubbard,M.J. Cohen,P. (1993) target new mechanism                  required glucose repression Saccharomvces cerevisiae. Mol. <br />    regulation protein phosphorylation. Trends Biochem. Sci., 18,               Cell.  <br /> </body></html>